Ask AI
Komal Jhaveri

Komal Jhaveri, MD, FACP, FASCO

Assistant Professor of Medicine, Section Head

Department of Medicine, Endocrine Therapy Research Program

Weill Cornell Medical College

New York, New York, United States of America

Patricia and James Cayne Chair for Junior Faculty
Associate Attending, Breast Medicine and Early Drug Development Services
Section Head, Endocrine Therapy Research Program
Memorial Sloan Kettering Cancer Center
Associate Attending, Weill Cornell Medical College
New York, New York

Explore Activities by Komal Jhaveri

Title
Format
Credit Type
Credits
Oral SERDs in HR+/HER2- Breast Cancer: A Step Forward in Precision Endocrine Therapy

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

0.25
Integration of Novel Antibody–Drug Conjugates in Advanced HER2-Low, Hormone Receptor–Positive, and Triple-Negative Breast Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
Comparison of expert treatment recommendations vs community healthcare providers: analysis from an online decision support tool for metastatic breast cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
TROP-2–Targeted Therapy: Redefining the Therapeutic Landscape in HER2-Negative Breast Cancer

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
TROP-2–Targeted Therapy: Redefining the Therapeutic Landscape in HER2-Negative Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Optimizing Outcomes and Quality of Life for Patients With Advanced Breast Cancer Through Effective Management of ADC-Associated Toxicities

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Optimizing Outcomes and Quality of Life for Patients With Advanced Breast Cancer Through Effective Management of ADC-Associated Toxicities

Content Format:

Slideset

Credit Type:

--

Credits:

--
Making Treatment Decisions for Metastatic Breast Cancer: An Interactive Decision Support Tool for Patients

Content Format:

Tool

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Treatment Guidance for Metastatic Breast Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--
How I Apply New Clinical Developments to the Management of Metastatic Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Evening With the Experts: Discussing the Rapidly Evolving Treatment Landscape for Early-Stage Breast Cancer

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Evaluating and Managing High-Risk Disease in HR+/HER2- EBC (Without gBRCA)

Content Format:

Slideset

Credit Type:

--

Credits:

--
Frequently Asked Questions: Expanding the Spectrum of HER2 Positivity in Advanced Breast Cancer With T-DXd

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
ExpressPoints Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: HER2-Positive Metastatic Breast Cancer Expert Guidance

Content Format:

Tool

Credit Type:

--

Credits:

--
Podcast Pearls: HER2-Positive Breast Cancer: Current Approaches for Quality Care

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
HER2-Positive Breast Cancer: Current Approaches for Quality Care

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Key Updates in the Treatment of Hormone Receptor–Positive Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expanding the Scope of Precision Care for Patients With HR-Positive Breast Cancers: Things You Should Know

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Selection and Sequencing of Targeted Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Assessing Risk and Individualizing Therapy in HR+/HER2- Early Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Practical Management of Adverse Events and Strategies to Promote Adherence with Targeted Therapies in HR-Positive Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--